Search by Drug Name or NDC
NDC 71858-0305-05 LICART 0.013 g/1 Details
LICART 0.013 g/1
LICART is a TOPICAL SYSTEM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by IBSA Pharma Inc.. The primary component is DICLOFENAC EPOLAMINE.
MedlinePlus Drug Summary
Transdermal diclofenac is used to treat short-term pain due to minor strains, sprains, and bruises in adults and children 6 years of age and older. Diclofenac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the body's production of a substance that causes pain.
Related Packages: 71858-0305-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Diclofenac Transdermal Patch
Product Information
| NDC | 71858-0305 |
|---|---|
| Product ID | 71858-0305_0b72418c-f33d-6338-e063-6394a90a8e0a |
| Associated GPIs | 90210030208520 |
| GCN Sequence Number | 079402 |
| GCN Sequence Number Description | diclofenac epolamine PATCH TD24 1.3 % TRANSDERM |
| HIC3 | Q5E |
| HIC3 Description | TOPICAL ANTI-INFLAMMATORY, NSAIDS |
| GCN | 45883 |
| HICL Sequence Number | 020420 |
| HICL Sequence Number Description | DICLOFENAC EPOLAMINE |
| Brand/Generic | Brand |
| Proprietary Name | LICART |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | diclofenac epolamine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SYSTEM |
| Route | TOPICAL |
| Active Ingredient Strength | 0.013 |
| Active Ingredient Units | g/1 |
| Substance Name | DICLOFENAC EPOLAMINE |
| Labeler Name | IBSA Pharma Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA206976 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71858-0305-05 (71858030505)
| NDC Package Code | 71858-0305-5 |
|---|---|
| Billing NDC | 71858030505 |
| Package | 3 POUCH in 1 CARTON (71858-0305-5) / 5 SYSTEM in 1 POUCH (71858-0305-4) |
| Marketing Start Date | 2020-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 23.9879 |
| Pricing Unit | EA |
| Effective Date | 2023-07-01 |
| NDC Description | LICART 1.3% PATCH |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis